DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
about
Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brainConvergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.Genetic risk prediction and neurobiological understanding of alcoholism.n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice.Food intake and blood cholesterol levels of community-based adults with mood disorders.Saturated long-chain fatty acids activate inflammatory signaling in astrocytes.Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oilA novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants.The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature.Red blood cells in Rett syndrome: oxidative stress, morphological changes and altered membrane organization.Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms.Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging.Significance of long chain polyunsaturated fatty acids in human health.Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice.Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly.Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial.Effects of oestradiol on brain lipid class and Fatty Acid composition: comparison between pregnant and ovariectomised oestradiol-treated rats.Omega-3 polyunsaturated fatty acid supplementation for improving peripheral nerve health: protocol for a systematic review.Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain
P2860
Q28732836-41743558-EADA-4B0E-A93B-7ECB61CDC70FQ30511829-4B3DE031-588C-44CC-97EE-E7EAC8808819Q33672725-B8F4AB0B-A68A-40C7-983B-AEC516326AC2Q34081729-AC35CAE4-5314-4855-9F99-93B243F867B1Q34158786-A60745AE-EEAB-488A-9885-49E162FB5AA6Q35812590-F5C414AA-5414-4EAB-9006-1E0CA3BE56E7Q36034152-04906EA1-2171-4D06-B6E1-7236DDF06F79Q36049510-728AE389-9DEE-48CE-ABB4-AAA638D29F04Q36810081-9F2AFE48-8292-49F3-AA5A-52D5D02D8397Q37729874-57FA4A7B-690E-4807-83C8-F64C986B1BD2Q38004705-285CFC4E-792D-4359-8D3B-951F67175C5CQ38166992-F454D8A3-0D3D-4C77-8578-01BC319AE00DQ38514719-0C2AFB51-7509-48ED-AE9A-51919BE72525Q38658538-02D90985-90FB-43CC-A3D2-0BB409613A6BQ38865940-984EA893-A036-40C6-A48E-CA67F7D6A560Q41158349-934A4C9F-F23F-48CA-9F6D-1906BD0472BDQ46270072-92225CAE-79FA-4B57-994F-54D71E3B00E9Q47623310-C464F7A6-B063-4432-BD40-2E5147DE39CEQ47761010-C40C6C2E-6BDD-42A9-9C2D-68706E9AA3BDQ48831356-490EF3E6-0315-44A2-BEF9-C1E6E96F2BE3Q51759254-2B55CDAF-1FF4-425E-9989-63C8A9895842Q53347902-BF62C615-1F3F-4CFC-9B7C-AE5440873AAEQ58801216-3426B4DD-90E5-445C-BA2C-24E8695C7A18
P2860
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@ast
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@en
type
label
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@ast
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@en
prefLabel
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@ast
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@en
P2860
P356
P1433
P1476
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.
@en
P2093
Robert K McNamara
P2860
P304
P356
10.3945/JN.109.113233
P407
P577
2010-02-10T00:00:00Z